Patrick Y. Wen - Concepedia

Author

Patrick Y. Wen

Also Known As

A. Chung, A. Rai, Andreas von Deimling, Bosenberg, Marcus, C Willett, C. McCluskey, Christina Tsien, GLOBE Study Investigators, J. Raizer, Joerg C Tonn

1.9K

Publications

86.1K

Citations

145

H-Index

233

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Center for Neuro-Oncology Massachusetts General Hospital

About

Patrick Y. Wen is an author at Dana-Farber Cancer Institute specializing in medicine, neuro-oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	69	230	26.5K
2	Health Sciences	37	86	6.2K
3	Engineering	15	17	4.6K
4	Natural Sciences	4	4	143
5	Arts	1	1	33

Patrick Y. Wen

468

Publications

56.6K

Citations

119

H-Index

Page 1

	Year	Citations
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group Patrick Y. Wen, David R. Macdonald, David A. Reardon, Journal of Clinical Oncology EngineeringHigh-grade GliomasBrain LesionResponse AssessmentGlioma	2010	3.7K
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma Henry S. Friedman, Michael D. Prados, Patrick Y. Wen, Journal of Clinical Oncology	2009	2.4K
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso, Cancer Cell Normalizes Tumor VasculatureNeuro-oncologyNovel TherapyMedicinePharmacology	2007	1.8K
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial Derin B. Keskin, Annabelle Anandappa, Jing Sun, Nature Neuro-oncologyTumor ImmunologyCancer ImmunosurveillanceGliomaImmunology	2018	1.4K
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Nature Medicine Neuro-oncologyNeoadjuvant Anti-pd-1 ImmunotherapyTumor ImmunologyCancer ImmunosurveillanceGlioma	2019	1.3K
Epidemiology of Brain Metastases Lakshmi Nayak, Eudocia Q. Lee, Patrick Y. Wen Current Oncology Reports Neuro-oncologyBrain MetastasesBrain Tumor BiologyNeurologyBrain Lesion	2011	1.3K
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED] Michael Glantz, Bernard F. Cole, Peter Forsyth, Neurology	2000	850
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic <i>BRAF</i> V600–Mutant Anaplastic Thyroid Cancer Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Journal of Clinical Oncology Trametinib TreatmentConclusion DabrafenibMedicineRadionuclide TherapyLocally Advanced	2017	848
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study Daniel Cagney, Allison Martin, Paul J. Catalano, Neuro-Oncology	2017	803
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors Amita Patnaik, Lee S. Rosen, Sara M. Tolaney, Cancer Discovery	2016	740

Page 1